Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 16/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.46 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31747263 | 0.91 | GPR119 (0.49) | GPR119KDM4EPKMIRAK1USP30 | |
| SCHEMBL31747481 | 0.90 | GPR119 (0.48) | GPR119KDM4EPKMIRAK1USP30 | |
| SCHEMBL31173852 | 0.81 | GPR119 (0.58) | GPR119USP30 | |
| SCHEMBL31752792 | 0.78 | GPR119 (0.49) | GPR119USP30FAAH | |
| SCHEMBL17966508 | 0.78 | DRD2 (0.43) | IRAK1 | |
| SCHEMBL31753585 | 0.78 | GPR119 (0.59) | GPR119USP30 | |
| SCHEMBL2999873 | 0.78 | GPR119 (0.54) | GPR119KDM4EPKMIRAK1USP30 | |
| SCHEMBL31753579 | 0.77 | GPR119 (0.49) | GPR119USP30FAAH | |
| SCHEMBL15431347 | 0.77 | IRAK1 (0.56) | GPR119IRAK1USP30 | |
| SCHEMBL1532753 | 0.76 | KDM4E (0.55) | GPR119KDM4EPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025262297-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | DARK BLUE THERAPEUTICS LTD (GB) | 2025-12-26 | — | — | WO | disclosed |
| EP-4667467-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | Dark Blue Therapeutics Ltd (GB) | 2025-12-24 | — | — | EP | disclosed |